Obese, insulin-resistant subjects and type 2 diabetic patients often have a pro-thrombotic state.
Atherothrombotic complications of the metabolic syndrome are partly due to a dysregulation of hemostasis. This induces a pro-thrombotic state that includes endothelial activation, platelet hyperactivity, hypercoagulability, and hypofibrinolysis.
Hypofibrinolysis because of elevated PAI-1 levels is a core feature of the metabolic Weight loss improves all pro-thrombotic factors, indicating that obesity is a modifiable risk factor for thrombosis.
Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortality. Heart 2008;94:457-62